Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ho ZV"'
Autor:
Ho ZV; Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.; Center for Biomedical Informatics, Brown University, Providence, Rhode Island, USA., Arias SA; Department of Psychiatry and Human Behavior, Brown University, Providence, Rhode Island, USA.; Department of Psychosocial Research, Butler Hospital, Providence, Rhode Island, USA., Kunicki ZJ; Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.; Department of Psychiatry and Human Behavior, Brown University, Providence, Rhode Island, USA.; Department of Psychosocial Research, Butler Hospital, Providence, Rhode Island, USA., Sarkar IN; Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.; Center for Biomedical Informatics, Brown University, Providence, Rhode Island, USA.; Rhode Island Quality Institute, Providence, Rhode Island, USA., Chen ES; Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.; Center for Biomedical Informatics, Brown University, Providence, Rhode Island, USA.
Publikováno v:
Journal of clinical psychology [J Clin Psychol] 2023 Nov; Vol. 79 (11), pp. 2542-2555. Date of Electronic Publication: 2023 Jul 11.
Autor:
Li T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Kikuchi O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Zhou J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Wang Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Pokharel B; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, USA., Bastl K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Gokhale P; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Knott A; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Zhang Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Doench JG; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Ho ZV; Department of Medicine, University of Chicago Medical Center, Chicago, Illinois, USA., Catenacci DV; Department of Medicine, University of Chicago Medical Center, Chicago, Illinois, USA., Bass AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, USA.; Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
JCI insight [JCI Insight] 2023 Feb 08; Vol. 8 (3). Date of Electronic Publication: 2023 Feb 08.
Autor:
Wu Z; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Zhou J; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Zhang X; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Zhang Z; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Xie Y; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Liu JB; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Ho ZV; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Panda A; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Committee on Immunology, The University of Chicago, Chicago, IL, USA., Qiu X; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Cejas P; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Cañadas I; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, PA, USA., Akarca FG; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., McFarland JM; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Nagaraja AK; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Goss LB; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Kesten N; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Si L; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA, USA., Lim K; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Liu Y; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Zhang Y; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Baek JY; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Liu Y; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Patil DT; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Katz JP; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Hai J; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Bao C; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Stachler M; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Qi J; Cancer Biology Department, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Ishizuka JJ; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Nakagawa H; Herbert Irving Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Medicine, Columbia University, New York, NY, USA., Rustgi AK; Herbert Irving Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Medicine, Columbia University, New York, NY, USA., Wong KK; Division of Hematology and Medical Oncology, Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA., Meyerson M; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Barbie DA; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Brown M; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Long H; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Bass AJ; Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. ab5147@cumc.columbia.edu.; Cancer Program, The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA. ab5147@cumc.columbia.edu.; Herbert Irving Comprehensive Cancer Center, Division of Hematology and Oncology, Department of Medicine, Columbia University, New York, NY, USA. ab5147@cumc.columbia.edu.
Publikováno v:
Nature genetics [Nat Genet] 2021 Jun; Vol. 53 (6), pp. 881-894. Date of Electronic Publication: 2021 May 10.
Autor:
Price C; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Gill S; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Ho ZV; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Davidson SM; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts., Merkel E; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., McFarland JM; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Leung L; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Tang A; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Kost-Alimova M; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Tsherniak A; Broad Institute of Harvard and MIT, Cambridge, Massachusetts., Jonas O; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts., Vazquez F; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Hahn WC; Broad Institute of Harvard and MIT, Cambridge, Massachusetts. william_hahn@dfci.harvard.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Publikováno v:
Cancer research [Cancer Res] 2019 May 15; Vol. 79 (10), pp. 2564-2579. Date of Electronic Publication: 2019 Mar 21.
Autor:
McFarland JM; Broad Institute of MIT and Harvard, Cambridge, 02142, MA, USA., Ho ZV; Broad Institute of MIT and Harvard, Cambridge, 02142, MA, USA., Kugener G; Broad Institute of MIT and Harvard, Cambridge, 02142, MA, USA., Dempster JM; Broad Institute of MIT and Harvard, Cambridge, 02142, MA, USA., Montgomery PG; Broad Institute of MIT and Harvard, Cambridge, 02142, MA, USA., Bryan JG; Broad Institute of MIT and Harvard, Cambridge, 02142, MA, USA., Krill-Burger JM; Broad Institute of MIT and Harvard, Cambridge, 02142, MA, USA., Green TM; Broad Institute of MIT and Harvard, Cambridge, 02142, MA, USA., Vazquez F; Broad Institute of MIT and Harvard, Cambridge, 02142, MA, USA.; Dana-Farber Cancer Institute, Boston, 02215, MA, USA., Boehm JS; Broad Institute of MIT and Harvard, Cambridge, 02142, MA, USA., Golub TR; Broad Institute of MIT and Harvard, Cambridge, 02142, MA, USA.; Dana-Farber Cancer Institute, Boston, 02215, MA, USA.; Harvard Medical School, Boston, 02115, MA, USA.; Boston Children's Hospital, Boston, 02115, MA, USA.; Howard Hughes Medical Institute, Chevy Chase, 20815, MD, USA., Hahn WC; Broad Institute of MIT and Harvard, Cambridge, 02142, MA, USA.; Dana-Farber Cancer Institute, Boston, 02215, MA, USA.; Harvard Medical School, Boston, 02115, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, 02115, MA, USA., Root DE; Broad Institute of MIT and Harvard, Cambridge, 02142, MA, USA., Tsherniak A; Broad Institute of MIT and Harvard, Cambridge, 02142, MA, USA. aviad@broadinstitute.org.
Publikováno v:
Nature communications [Nat Commun] 2018 Nov 02; Vol. 9 (1), pp. 4610. Date of Electronic Publication: 2018 Nov 02.